More Syntara Limited news
Syntara LimitedASX: SNT

Pharmaxis Announces Results of Pivotal CF Clinical Trial

Jun 12, 2017 at 11:54 PM EDT · Issued by Syntara Limited

Filed with ASX · Jun 12, 2017 at 11:54 PM EDT · 4 pages · English

On 6ix: 6ix.com/news/pharmaxis-announces-results-of-pivotal-cf-clinical-trial

Syntara Limited on 6ix

Earlier from Syntara

  • Pharmaxis Set to Generate Further Euro 10m Milestone PaymentMay 14, 2017
  • Pharmaxis Appoints Chiesi as Bronchitol Distributor in ItalyMay 8, 2017
  • Appendix 4C - quarterly cash flowApr 18, 2017
  • Quarterly Shareholder Update March 2017Apr 17, 2017
  • Synairgen Collaboration ProgressMar 12, 2017

Later from Syntara

  • Appendix 4C - quarterly June 2017Jul 28, 2017
  • Preliminary Final Report June 2017Aug 10, 2017
  • Positive Recommendation for Broader Bronchitol Access in AusAug 18, 2017
  • Boehringer Ingelheim Initiates Phase IIa Study in NASHAug 24, 2017
  • Antifibrotic LOXL2 Program Clears Preclinical DevelopmentSep 5, 2017
All Syntara news releases↗

Follow Syntara into a list and get an email when it puts out news.

Follow Syntara
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer